Search Results

There are 85149 results for: content related to: A methamphetamine analog ( N,α -diethyl-phenylethylamine) identified in a mainstream dietary supplement

  1. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model

    Drug Testing and Analysis

    Volume 4, Issue 7-8, July-August 2012, Pages: 556–576, Clint E. Canal and Drake Morgan

    Version of Record online : 19 APR 2012, DOI: 10.1002/dta.1333

  2. Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

    Drug Testing and Analysis

    Volume 4, Issue 7-8, July-August 2012, Pages: 649–659, Torsten Passie, Hinderk M. Emrich, Matthias Karst, Simon D. Brandt and John H. Halpern

    Version of Record online : 26 JUN 2012, DOI: 10.1002/dta.1377

  3. A review of designer anabolic steroids in equine sports

    Drug Testing and Analysis

    Christopher C. Waller and Malcolm D. McLeod

    Version of Record online : 18 NOV 2016, DOI: 10.1002/dta.2112

  4. Pyrolysis of drugs of abuse: a comprehensive review

    Drug Testing and Analysis

    Volume 7, Issue 6, June 2015, Pages: 445–456, Suzanne Bell and Corey Nida

    Version of Record online : 13 APR 2015, DOI: 10.1002/dta.1794

  5. Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 778–787, Marie Claire Van Hout

    Version of Record online : 11 MAR 2014, DOI: 10.1002/dta.1622

  6. New phenethylamines in Europe

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 808–818, L. A. King

    Version of Record online : 5 NOV 2013, DOI: 10.1002/dta.1570

  7. You have free access to this content
    Annual banned-substance review: analytical approaches in human sports drug testing

    Drug Testing and Analysis

    Volume 7, Issue 1, January 2015, Pages: 1–20, Mario Thevis, Tiia Kuuranne, Hans Geyer and Wilhelm Schänzer

    Version of Record online : 26 DEC 2014, DOI: 10.1002/dta.1769

  8. Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 7–16, Natalia Battista, Manuel Sergi, Camilla Montesano, Sabino Napoletano, Dario Compagnone and Mauro Maccarrone

    Version of Record online : 11 NOV 2013, DOI: 10.1002/dta.1574

  9. Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization

    Drug Testing and Analysis

    Volume 5, Issue 1, January 2013, Pages: 27–45, Delphine Psychoyos and K. Yaragudri Vinod

    Version of Record online : 13 AUG 2012, DOI: 10.1002/dta.1390

  10. Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

    Drug Testing and Analysis

    Volume 4, Issue 7-8, July-August 2012, Pages: 543–555, Michael P. Bogenschutz and Jessica M. Pommy

    Version of Record online : 4 JUL 2012, DOI: 10.1002/dta.1376

  11. Fluorine in psychedelic phenethylamines

    Drug Testing and Analysis

    Volume 4, Issue 7-8, July-August 2012, Pages: 577–590, Daniel Trachsel

    Version of Record online : 28 FEB 2012, DOI: 10.1002/dta.413

  12. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs)

    Drug Testing and Analysis

    Volume 9, Issue 3, March 2017, Pages: 500–517, Rahul S. Pawar and Erich Grundel

    Version of Record online : 3 JUN 2016, DOI: 10.1002/dta.1980

  13. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis

    Drug Testing and Analysis

    Volume 4, Issue 11, November 2012, Pages: 830–845, Simon Beuck, Wilhelm Schänzer and Mario Thevis

    Version of Record online : 24 FEB 2012, DOI: 10.1002/dta.390

  14. Challenges in detecting substances for equine anti-doping

    Drug Testing and Analysis

    A. G. Fragkaki, N. Kioukia-Fougia, P. Kiousi, M. Kioussi and M. Tsivou

    Version of Record online : 5 APR 2017, DOI: 10.1002/dta.2162

  15. You have free access to this content
    History full circle: ‘Novel’ sympathomimetics in supplements

    Drug Testing and Analysis

    Volume 8, Issue 3-4, March-April 2016, Pages: 283–286, Nicolas Rasmussen and Peter H. J. Keizers

    Version of Record online : 2 NOV 2015, DOI: 10.1002/dta.1852

  16. Annual banned-substance review: analytical approaches in human sports drug testing

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 164–184, Mario Thevis, Tiia Kuuranne, Hans Geyer and Wilhelm Schänzer

    Version of Record online : 27 NOV 2013, DOI: 10.1002/dta.1591

  17. Annual banned-substance review: analytical approaches in human sports drug testing

    Drug Testing and Analysis

    Volume 5, Issue 1, January 2013, Pages: 1–19, Mario Thevis, Tiia Kuuranne, Hans Geyer and Wilhelm Schänzer

    Version of Record online : 10 DEC 2012, DOI: 10.1002/dta.1441

  18. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 143–154, Kim Wolff and Atholl Johnston

    Version of Record online : 11 DEC 2013, DOI: 10.1002/dta.1588

  19. Equine performance genes and the future of doping in horseracing

    Drug Testing and Analysis

    Tessa Wilkin, Anna Baoutina and Natasha Hamilton

    Version of Record online : 30 MAY 2017, DOI: 10.1002/dta.2198

  20. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 614–632, Hamilton Morris and Jason Wallach

    Version of Record online : 26 MAR 2014, DOI: 10.1002/dta.1620